Introduction {#Sec1}
============

Resveratrol, which is a naturally occurring hydroxystilbene, has a broad range of biological activities and can be used in treatments for the metabolic syndrome (Cherniack [@CR1]; Xianfeng-Huang and Zhu [@CR17]). It can lower the weight, blood pressure, glucose, and insulin resistance in rodents, and a human trial with it is currently underway. However, the water-insolubility of resveratrol limits its pharmacological exploitation but its water-soluble derivatives, resveratrol 3-*O*-β-D-glucoside and resveratrol 4′-*O*-β-D-glucoside, show pharmaceutical properties such as cancer prevention (Ingram et al. [@CR5]), anti-oxidant activity (Tikkanen et al. [@CR14]) and estrogenic activity (Gehm et al. [@CR3]). The glucosidation of *trans*-resveratrol is therefore of considerable importance the further exploitation of *trans*-resveratrol.

Cultured plant cells can be used to convert organic molecules to more useful compounds (Suga and Hirata [@CR13]) by carrying out hydrolysis, oxidation, reduction, esterification, isomerization, and glycosylation reactions (Ishihara et al. [@CR6]; Suga and Hirata [@CR13]). Glycosylation of bioactive compounds can enhance water solubility, physicochemical stability, intestinal absorption, and biological half-life (Vogt and Jones [@CR15]). Many secondary metabolites accumulate in the form of glycosides in plants suggesting that suspension of such cells would contain glucosyltransferases (GTs), which catalyze the conjugation of an aglycone and a glucosyl donor molecule (Furuya et al. [@CR2]).

We previously reported that the plant cell cultures from *Phytolacca americana* (*Pa*) glycosylated exogenous compounds (Noguchi et al. [@CR10]). Three glucosyltransferase cDNAs (*Pa*GT1-3) were isolated from *P. americana*. In this study, we report that *Pa*GT3, which accepts a broad range of substrates, could catalyze regio- and stereo-specific glucosidation of resveratrol using a purified enzyme as well as the recombinant *E. coli* cells bearing the *Pa*GT3 gene. Furthermore, we constructed the *Pa*GT3 model structure and performed mutagenesis studies in order to examine amino acid residues involved in the substrate recognition and the catalytic process.

Methods and materials {#Sec2}
=====================

General {#Sec3}
-------

All chemicals were purchased from Wako, Nakalai, and Sigma-Aldrich, and enzymes for mutagenesis were obtained from Toyobo. HRFAB-MS spectra were measured on a JEOL MS station JMS-700 spectrometer. The ^1^H-and ^13^C-NMR spectra were recorded using Varian XL-400 spectrometer.

Glucosidation of *trans*-resveratrol with cultured plant cells {#Sec4}
--------------------------------------------------------------

Callus tissues from *Phytolacca americana* L. were prepared (see Hamada et al. [@CR4]). Callus tissue (20 g) was cultured under light for 4 weeks, transferred to an Erlenmeyer flask (300 ml) containing 100 ml Murashige and Skoog (MS) liquid medium, and cultured with continuous shaking at 25°C. Ten mg of *trans*-resveratrol was added to the flask and the cells were incubated for an additional 3 days at 25°C. Following incubation, the cells were isolated by filtration, and extracted with methanol (200 ml) for 24 h. The methanol fraction was concentrated and partitioned between water (100 ml) and ethyl acetate (300 ml); the ethyl acetate fraction was analyzed by HPLC. The substrate and glucosylated products were separated using YMC-Pack R&D ODS column and acetonitrile/water (15:85, v/v) at 1 ml/min, with detection at 280 nm. Product yields were calculated based on the peak area from the HPLC profile using the calibration curves prepared by similar HPLC analyses of known glycosides.

Glucosidation of *trans*-resveratrol by purified *Pa*GT3 enzyme {#Sec5}
---------------------------------------------------------------

*Pa*GT3 cDNA was cloned into pQE30 containing 6X-His tag at the *N*-terminus, and the resulting pQE30-*Pa*GT3 plasmid was transformed into *E. coli* M15 cells. The transformants were cultured with continuous shaking at 30°C in the Luria- Bertani (LB) broth containing 50 μg ampicillin/ml. After 16 h, 20 ml culture was transferred to 2 l fresh LB broth, and cultured with shaking at 30°C; at OD~600~ = 1, IPTG was added to 0.1 mM, followed by incubation at 30°C for an additional 16 h. To purify the *Pa*GT3 enzyme, the harvested cells were collected by centrifugation for 10 min 5,000×*g* resuspended in buffer H (15 mM potassium phosphate, 1 mM EDTA, 2 mM 2-mercapotoethanol). Cells were lysed by sonication, and cellular debris were removed by centrifugation for 15 min 5,000×*g*, and the supernatant was applied to a His-accept column equilibrated with buffer H. The column was washed with buffer H to remove impurities, and the bound *Pa*GT3 enzyme was eluted with buffer H supplemented with 200 mM imidazole. The purified *Pa*GT3 enzyme solution was dialyzed for 16 h at 4°C with 50 mM potassium phosphate buffer (pH 7.2).

The His-20 *Pa*GT3 mutants were constructed from pQE30-*Pa*GT3 by polymerase chain reaction (PCR) using primers 5′-GCCCATGGGGCCATGATCCCG-3′ and 5′- CGGGATCATGGCCCCATGGGC-3′ for H20A *Pa*GT3, and 5′-GCCCATGGGGATATGATCCCG-3′ and 5′- CGGGATCATATCCCCATGGGC-3′ for H20D *Pa*GT3. The plasmids with His-20 mutations were transformed into *E. coli* M15 cells and characterized by sequencing.

Glucosidation reactions were performed at 30°C for 60 min in 0.5 ml 50 mM potassium phosphate buffer (pH 7.2) supplemented with 50 μM *trans*-resveratrol, 100 μM UDP-glucose, and 1 μM *Pa*GT3. The substrates and glucosylated products were separated using Insertsil ODS-3 column, and the standard gradient program, which was as follows: the ratio of water (A) to acetonitrile (B) was initially 80:20 at a time 0--15 min, then the A:B ratio was linearly increased from 80:20 (v/v) at t = 15 min to 20:80 (v/v) at t = 40 min followed by a final wash with 100% acetonitrile. The UV--visible detector was set at 280 nm.

Glucosidation of *trans*-resveratrol by the *E. coli* cell cultures {#Sec6}
-------------------------------------------------------------------

*E. coli* M15 cells containing pQE30-*Pa*GT3 were cultured as described above in 10 ml LB medium containing 0.1 mg *tans*-resveratrol/l and 50 μg/ml ampicillin. After induction for 16 h with 0.1 mM IPTG, the cells and the medium were separated, and the products were extracted from the medium with 2 × 10 ml ethyl acetate. Ethyl acetate was evaporated using a rotary evaporator and the residue was analyzed by HPLC. Alternatively, the medium was applied to Diaion HP-20 (1 g), washed with water, and eluted with methanol. The methanol solution was analyzed by HPLC using the standard gradient program.

Analysis {#Sec7}
--------

The ^1^H-and ^13^C-NMR spectra were recorded in CD~3~OD. The chemical shifts were expressed in δ (ppm) referring to TMS. ^1^H-NMR spectra of *trans*-resveratrol 3-*O*-β-glucoside and 4′-*O*-β-glucoside were essentially identical to those of authentic spectra (Weis et al. [@CR16]). The β-configuration was confirmed by anomeric proton signals at δ 4.80 (1H, d, *J* = 7.6 Hz) and δ 4.88 (1H, d, *J* = 7.6 Hz) for *trans*-resveratrol 3-*O*-β-glucoside and 4′-*O*-β-glucoside, respectively. ^13^C-NMR of *trans*-resveratrol 3-*O*-β-glucoside: δ139.3 (C-1), 107.1 (C-2), 158.0 (C-3), 102.7 (C-4), 158.8 (C-5), 104.7 (C-6), 125.1 (C-7), 128.5(C-8), 129.9 (C-1′), 128.0 (C-2′), 115.5 (C-3′), 157.2 (C-4′), 115.5 (C-5′), 127.8 (C-6′), 100.6 (C-1″), 73.3 (C-2″), 76.7 (C-3″), 69.8 (C-4″), 77.1 (C-5″), 60.8 (C-6″). ^13^C NMR of *trans*-resveratrol 4′-*O*-β-glucoside: δ138.3 (C-1), 104.4 (C-2), 158.4 (C-3), 102.0 (C-4), 158.2 (C-5), 104.4 (C-6), 127.1 (C-7), 127.5(C-8), 130.7 (C-1′), 127.3 (C-2′), 116.3 (C-3′), 156.8 (C-4′), 116.3 (C-5′), 127.3 (C-6′), 100.2 (C-1″), 73.2 (C-2″), 76.6 (C-3″), 69.7 (C-4″), 77.0 (C-5″), 60.7 (C-6″).

Construction of the homology modeling of *Pa*GT3 {#Sec8}
------------------------------------------------

The homology model of *Pa*GT3 was constructed using the Swiss-model (<http://swissmodel.expasy.org>) with the crystal structure of GT from *Vitis vinifera* (pdb code: 2C1Z) as a template (Offen et al. [@CR11]). The model and the template were compared using the Swiss-pdb viewer (<http://spdbv.vital-it.ch/>) and PyMol (<http://www.pymol.org/>) (Kiefer et al. [@CR7]; Kopp and Schwede [@CR8]; Peitsch [@CR12]).

Results and discussion {#Sec9}
======================

The production of *trans*-resveratrol 3-*O*-β-glucoside and 4′-*O*-β-glucoside by *Pa*GT3 {#Sec10}
-----------------------------------------------------------------------------------------

Cell suspension cultures of *P. americana* could glucosylate *trans*-resveratrol to synthesize 3-*O*-β-glucoside and 4′-*O*-β-glucoside (Scheme [1](#Sch1){ref-type="fig"}). In this system, the addition of UDP-glucose was not required because glucosyl donor molecules were regenerated. Conjugation products were extracted from the cells and purified by reverse phase HPLC (Fig. [1](#Fig1){ref-type="fig"}a). Under the reverse phase HPLC conditions, 4′-*O*-β-glucoside eluted faster than 3-*O*-β-glucoside, as previously reported (Weis et al. [@CR16]). The HRFABMS spectra of these isolated glucosides showed a pseudomolecular ion \[M + H\]^+^ peak at *m/z* 391, suggesting a molecular formula of C~20~O~8~H~22~ (calculated for 390). The comparison of NMR spectra with those of the known monoglucoside standards confirmed the synthesis of *trans*-resveratrol 3-*O*-β-glucoside and 4′-*O*-β-glucoside in the culture medium. Interestingly, the product distribution was considerably altered by the addition of 2,4-dichlorophenoxyacetic acid as a synthetic auxin to the culture medium (Fig. [1](#Fig1){ref-type="fig"}b). The synthesis of 4′-*O*-β-glucoside was notably enhanced following incubation with the plant hormone.Scheme 1Glucosidation of *trans*-resveratrolFig. 1HPLC profiles of the glucosylated products obtained from incubation with **a***Phytolacca americana* cells in the absence of auxin, **b***P. americana* cells in the presence of 2,4-dichlorophenoxyacetic acid, and **c** the purified *Pa*GT3 enzyme. \* and \*\* indicate *trans*-resveratrol 4′-*O*-β-glucoside and *trans*-resveratrol 3-*O*-β-glucoside, respectively. **d** The starting material *trans*-resveratrol was eluted at 31 min

To investigate the changes in regiospecificity, we heterologously expressed *Pa*GT3 in *E. coli* and purified the enzyme to synthesize the glucosides. When *trans*-resveratrol was incubated with UDP-glucose in the presence of *Pa*GT3, 4′-*O*-β-glucoside was obtained as the major product (Fig. [1](#Fig1){ref-type="fig"}c). The ratio of peak area for 4′-*O*-β-glucoside to that for 3-*O*-β-glucoside in the HPLC profile was 10:3. The product distribution was not altered following the addition of 2,4-dichlorophenoxyacetic acid, phenyl acetic acid, or 1-naphthalene acetic acid, indicating that these hormones do not interact directly with the purified *Pa*GT3 enzyme. From these observations, we believe that 2,4-dichlorophenoxyacetic acid may induce the expression of *Pa*GT3 in the cultured cells, resulting in enhanced 4′-*O*-β-glucoside production. The expression and purification of *Pa*GT1 and *Pa*GT2 are now under way to examine the regiospecificity for the glucosidation reaction catalyzed by these isozymes.

Biotransformation of *trans*-resveratrol by *E. coli* cells {#Sec11}
-----------------------------------------------------------

The results of this study show that purified *Pa*GT3 catalyzes the glucosidation of *trans*-resveratrol. Next, we attempted to use *E. coli* cells expressing *Pa*GT3 gene to promote the glucoside synthesis because *E. coli* cells grow faster than *P. americana* cells. When *Pa*GT3-expressing *E. coli* cells were cultured in the presence of *trans*-resveratrol, glucoside products of trans-resveratrol were detected in the medium of overnight culture. Interestingly, endogenous glucosyl donor molecules were sufficient for the reaction, since the reaction occurred even when UDP-glucose was not added to the medium. The products were extracted from the medium using ethyl acetate and identified by reverse-phase HPLC as 3-*O*-β--glucoside and 4′-*O*-β--glucoside. The glucosidation of *trans*-resveratrol was almost 100% using this method, and a peak corresponding to resveratrol, starting material, was not observed in the HPLC profile (Fig. [2](#Fig2){ref-type="fig"}). This was a considerable improvement because only 39% of *trans*-resveratrol was glucosylated in *P. americana* cell cultures. Furthermore, the use of *E. coli* cells allowed the incubation time to be shortened from 3 days to 1. The glucoside products accumulated in the medium and could not be isolated from the cell extracts. Since *Pa*GT3 is not secreted from the *E. coli* cells, *trans*-resveratrol and its glucoside products may pass through the cell membrane. These results indicate that *Pa*GT3 expressing *E. coli* cells utilize endogenous UDP-glucose to convert *trans*-resveratrol completely into the glucosides.Fig. 2HPLC profiles of glucosylated products obtained from the incubation of *E. coli* expressing **a** wild type *Pa*GT3 gene and **b** H20A *Pa*GT3 gene. HPLC profile **b** was similar to that obtained in the incubation with *E. coli* expressing H20D *Pa*GT3 gene. \*, \*\*, and \*\*\* indicate *trans*-resveratrol 4′-*O*-β-glucoside, *trans*-resveratrol 3-*O*-β-glucoside, and *trans*-resveratrol, respectively

We also found that Diaion HP20 could be used to isolate the glucoside products from the medium instead of extracting the glucosides with ethyl acetate. The aromatic moiety of *trans*-resveratrol glucosides appeared to interact with the non-polar hydrophobic surface of HP20 resin by van der Waals force, and the glucoside products bound on the resin were eluted with methanol. The use of HP20 is convenient for the isolation of glucosylated products from the medium obtained by a large scale incubation.

Molecular modeling and mutagenesis studies {#Sec12}
------------------------------------------

The X-ray crystal structure of *Pa*GT3 may yield important insights into the reaction mechanism; however, the structure of *Pa*GT3 has not yet been determined. Therefore, we constructed a structural model of *Pa*GT3 using the crystal structure of GT from *V. vinifera* (*Vv*GT) as a template (Offen et al. [@CR11])*.* The predicted *Pa*GT3 structure was then superimposed upon the crystal structure of *Vv*GT bearing UDP-2-deoxy-2-fluoro glucose (a nontransferable donor molecule) and kaempferol (a glucose acceptor molecule) at the active site for comparison (Fig. [3](#Fig3){ref-type="fig"}a). A putative model structure of *Pa*GT3 implies that Gln-395 may play an important role in appropriate positioning of UDP-glucose, a glucose donor molecule. *trans*-Resveratrol, a glucose acceptor molecule, may bind *Pa*GT3 in the hydrophobic pocket surrounded by Phe-126, Leu-155, and Phe-392. A histidine residue conserved in the active site of GTs normally accept a proton from the hydroxy group of an acceptor molecule and promote the nucleophilic attack on C1 of UDP-glucose (Fig. [3](#Fig3){ref-type="fig"}b) (Lairson and Withers [@CR9]). The model structure of *Pa*GT3 clearly suggests that His-20 rather than His-18 is the catalytic residue. Moreover, the hydrogen-bonding interaction between the carboxy side chain of Asp-124 and the Nδ atom of His-20 might increase the basicity of this imidazole to enhance the nucleophilicity.Fig. 3**a** The active site of *Pa*GT3 model. The predicted *Pa*GT3 structure was superimposed upon the crystal structure of *Vv*GT bearing UDP-2-deoxy-2-fluoro glucose (nontransferable donor) and kaempferol (acceptor). UDP-2-deoxy-2-fluoro glucose (*U*), kaempferol (*K*), and some selected active site residues of *Pa*GT3 are shown. **b** Schematic diagram of active site of *Pa*GT3 model. The dashed lines indicate hydrogen bonds. A hydrogen bond between His-20 and the 4′-hydroxy group of *trans*-resveratrol may promote nucleophilic attack on C1 of UDP-glucose to produce 4′-β-*O*-glucoside

In order to determine if His-20 is a catalytically important residue, we decided to substitute His-20 with Ala and Asp and measure the GT activity of these mutants. The expression levels of the mutated enzymes were comparable to the wild type enzyme. We could successfully purify the mutant enzymes using nickel-nitrilotriacetic acid affinity columns and analyzed their GT activity (Fig. [4](#Fig4){ref-type="fig"}). We were unable to detect glucosidation products in the reaction mixture containing *trans*-resveratrol (acceptor), UDP-glucose (donor), and the H20A and H20D *Pa*GT3 mutant enzymes. The incubation of *E. coli* cells expressing the H20A and H20D mutant *Pa*GT3 enzymes in the medium containing *trans*-resveratrol did not produce the glucosides either (Fig. [2](#Fig2){ref-type="fig"}). These results provided the experimental evidence that His-20 in the active site was critical for the GT reaction. The mutagenesis of residues interacting with an acceptor molecule might allow us to construct a novel enzyme glucosylating a broad range of biologically active molecules.Fig. 4SDS-PAGE of the purified *1* H20A and *2* H20D *Pa*GT3 enzymes

Conclusions {#Sec13}
===========

Purified *Pa*GT3 glucosylates *trans*-resveratrol to 4′-*O*-β-glucoside (a major product) and 3-*O*-β-glucoside (a minor product). Based on homology modeling, resveratrol may bind *Pa*GT3 in a hydrophobic pocket similar to the GT from *V. vinifera* (*Vv*GT)*.* The predicted structure of *Pa*GT3 indicated that His-20 probably was a catalytically important residue for the nucleophilic attack of the aglycone on the C1 of UDP-glucose. This was confirmed by mutational analysis because H20A and H20D *Pa*GT3 mutant enzymes lacked GT activity. Furthermore, *E. coli* expressing the *Pa*GT3 gene was used for the glycoconjugation of *trans*-resveratrol in the culture medium. The advantages of using *E. coli* cell cultures are a shorter incubation time compared with cultured plant cells, no need for the addition of exogenous glucosyl donor compounds, such as UDP-glucose, and the almost complete conversion of the aglycone to the glucoside products. The use of *E. coli* cell cultures combined with molecular engineering of *Pa*GT3 may provide a new biocatalyst for the glucosidation of aromatic compounds.
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